Medartis Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Matthias Schupp
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 3.8yrs |
Board average tenure | 3.7yrs |
Recent management updates
Recent updates
CEO
Matthias Schupp (60 yo)
less than a year
Tenure
Mr. Matthias Schupp is CEO & Member of the Executive Management Board of Medartis Holding AG from 2024. He had been Chief Executive Officer of Neodent at Straumann Holding AG since 2015 until 2024 and serv...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Vice Chairman | 26.9yrs | CHF 291.97k | 41.37% CHF 300.9m | |
CEO & Member of the Executive Management Board | less than a year | no data | no data | |
CFO & Member of the Executive Management Board | 3.8yrs | no data | 0.029% CHF 212.5k | |
VP of EMEA & Member of Executive Management Board | 4.3yrs | no data | 0.053% CHF 388.7k | |
CTO & Member of the Executive Board | 4.1yrs | no data | 0.017% CHF 123.4k | |
COO & Member of Management Board | 2.9yrs | no data | 0.0027% CHF 19.5k | |
Chief Human Resources Officer & Executive Management Board Member | no data | no data | no data | |
Head of Regulatory Affairs | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
55yo
Average Age
Experienced Management: MEDZ's management team is considered experienced (3.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Vice Chairman | 26.9yrs | CHF 291.97k | 41.37% CHF 300.9m | |
Independent Non-Executive Director | 6.9yrs | CHF 188.29k | 0.19% CHF 1.4m | |
Independent Chairman | 4.7yrs | CHF 568.06k | 0.065% CHF 473.0k | |
Independent Director | 2.7yrs | CHF 112.76k | 0.0096% CHF 70.0k | |
Independent Non Executive Director | 14.9yrs | CHF 161.68k | 4.55% CHF 33.1m | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Director | 2.7yrs | CHF 171.53k | 0.0072% CHF 52.5k |
3.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: MEDZ's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 12:46 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medartis Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Eric Le Berrigaud | Bryan Garnier & Co |
Hugo Solvet | Bryan Garnier & Co |
Christoph Gretler | Credit Suisse |